Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices 47651 

by provisions of Public Law 92–463, as 

amended, (5 U.S.C. app. 2), which sets 

forth standards for the formation and 

use of Advisory Committees. 

ACIM advises the Secretary of Health 

and Human Services on department 

activities and programs directed at 

reducing infant mortality and improving 

the health status of pregnant women 

and infants. ACIM represents a publicprivate partnership at the highest level 

to provide guidance and focus attention 

on the policies and resources required 

to address the reduction of infant 

mortality and the improvement of the 

health status of pregnant women and 

infants. With a focus on life course, the 

ACIM addresses disparities in maternal 

health to improve maternal health 

outcomes, including preventing and 

reducing maternal mortality and severe 

maternal morbidity. ACIM provides 

advice on how best to coordinate 

myriad federal, state, local, and private 

programs and efforts that are designed 

to deal with the health and social 

problems impacting infant mortality and 

maternal health, including 

implementation of the Healthy Start 

program and maternal and infant health 

objectives from the National Health 

Promotion and Disease Prevention 

Objectives (i.e., Healthy People 2030). 

The agenda for the September 21–22, 

2021, meeting is being finalized and 

may include the following topics: 

Federal program updates; discussion of 

recommendations by ACIM to the 

Secretary; fatality review programs; 

health of indigenous mothers and 

infants; financing of care; and patientphysician racial concordance in health 

care. Refer to the ACIM website for any 

updated information concerning the 

meeting. 

Members of the public will have the 

opportunity to provide written or oral 

comments. Requests to submit a written 

statement or make oral comments to the 

ACIM should be sent to Vanessa Lee, 

using the email address above at least 

three business days prior to the meeting. 

Public participants may submit written 

statements in advance of the scheduled 

meeting by emailing SACIM@hrsa.gov. 

Oral comments will be honored in the 

order they are requested and may be 

limited as time allows. 

Individuals who plan to attend and 

need special assistance or another 

reasonable accommodation should 

notify Vanessa Lee at the contact 

information listed above at least 10 

business days prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–18378 Filed 8–25–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Advisory 

Dental and Craniofacial Research 

Council, September 9, 2021, 10:00 a.m. 

to September 9, 2021, 4:00 p.m., 

National Institutes of Health, National 

Institute of Dental and Craniofacial Res., 

6701 Democracy Blvd., Bethesda, MD 

20892 which was published in the 

Federal Register on August 13, 2021, FR 

Doc. 2021–17302, 86 FR 44736. 

This meeting is being amended to 

change the times of the Open and 

Closed sessions. The Open session will 

be from 9:00 a.m. to 2:30 p.m. and will 

be videocast and can be accessed from 

the NIH Videocasting and Podcasting 

website (http://videocast.nih.gov/). The 

Closed session will be from 2:45 p.m. to 

3:30 p.m. The meeting is partially 

Closed to the public. 

Dated: August 23, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18401 Filed 8–25–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request Electronic 

Individual Development Plan (eIDP) 

(National Eye Institute) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Dr. Cesar E. Perez-Gonzalez, 

Training Director, Office of the 

Scientific Director, National Eye 

Institute, NIH, Building 31, Room 6A22, 

MSC 0250, Bethesda, Maryland 20892 

or call non-toll-free number (301) 451– 

6763 or Email your request, including 

your address to: cesarp@nei.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on May 24, 2021, page 27856– 

27857 (86 FR 27856) and allowed 60 

days for public comment. No public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. 

The National Eye Institute (NEI), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Electronic 

Individual Development Plans, 0925– 

NEW, XX/XX/XXXX, National Eye 

Institute (NEI), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: The National Eye Institute’s 

(NEI) Office of the Scientific Director 

(OSD) goal is to train the next 

generation of vision researchers and 

ophthalmologists. Trainees who 

participate in NEI research come with 

different levels of education (student, 

postbaccalaureate, predoctoral 

including graduate and medical 

students, postdoctoral fellows) and for 

different amounts of time (6 months to 

5 years). Training at the NEI focuses on 

scientific and professional skill 

development. To enhance their chances 

of obtaining their ideal career, 

completing an annual Individual 


jbell on DSKJLSW7X2PROD with NOTICES
47652 Federal Register / Vol. 86, No. 163 / Thursday, August 26, 2021 / Notices 

Development Plan (IDP) is an important 

step in helping a trainee’s career and 

professional development and is 

standard practice in graduate and 

postdoctoral education. An IDP is an 

effective tool for trainees to think about 

their career goals and skills needed to 

achieve them during their time at the 

NEI. Trainees work together with their 

research mentor to organize and 

summarize their research projects, 

consider career goals, and set training 

goals and expectations, both for the 

mentee and mentor. 

This information collection request is 

to implement an electronic Individual 

Development Plan (eIDP). The data 

collected comes from a detailed 

questionnaire focused on responses to 

professional goals and expectations 

while they are at the NEI. It is expected 

that the trainees will complete the eIDP 

annually and by doing so, it will help 

enhance the effectiveness of their 

training by setting clear goals that can 

be monitored not only by the trainee 

themselves but also by their mentor, the 

Training Director, and their 

Administrative Officer. In addition to 

this eIDP, the system will also 

implement an electronic exit survey. 

The data collected comes from a 

detailed questionnaire focused on 

responses to questions focused on 

trainee mentoring and professional 

experiences at the NEI as well as their 

plans after they depart. It is expected 

that the trainees will complete at the 

end of their tenure and that by doing so, 

the NEI Training Program can learn 

about ways to improve career 

development opportunities for future 

trainees as well as learn more about 

trainee job choices to better advise 

fellows. Additionally, we can use the 

survey to help determine mentor 

effectiveness and help identify problems 

in mentoring at the NEI. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

213. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

time per 

response 

(in hours) 

Total annual 

burden hour 

eIDP (Attachment 1) ......................... Individuals ........................................ 150 1 1 150 

Exit Survey Part 1 (Attachment 2) .... Individuals ........................................ 150 1 5/60 13 

Exit Survey Part 2 (Attachment 3) .... Individuals ........................................ 150 1 20/60 50 

Total ........................................... ........................................................... 150 150 ........................ 213 

Dated: August 19, 2021. 

Cesar E. Perez-Gonzalez, 

Training Director, National Eye Institute, 

National Institutes of Health. 

[FR Doc. 2021–18393 Filed 8–25–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–6: NCI 

Clinical and Translational Cancer Research. 

Date: October 12, 2021. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W240, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W240, Rockville, 

Maryland 20850, 240–276–5122, 

hasan.siddiqui@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–1: NCI 

Clinical and Translational Cancer Research. 

Date: October 28, 2021. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W242, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Zhiqiang Zou, M.D., Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W242, Rockville, 

Maryland 20850, 240–276–6372, zouzhiq@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Metastasis 

Research Network (U54). 

Date: October 28–29, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W238, Rockville, Maryland 20850, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Proteogenomic Tumor Analysis. 

Date: November 3, 2021. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W114, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W114, Rockville, Maryland 

20850, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; R03 

Omnibus and R21 Clinical and Translational 

Research. 

Date: November 3, 2021. 

Time: 10:00 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W556, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Kamal Datta, M.D., 

Scientific Review Officer, Program 


jbell on DSKJLSW7X2PROD with NOTICES